ZA885417B - Pharmaceutical composition for intranasal administration,comprising gh-releasing hormone,a cholinergic agonist and in case a bile salt - Google Patents

Pharmaceutical composition for intranasal administration,comprising gh-releasing hormone,a cholinergic agonist and in case a bile salt

Info

Publication number
ZA885417B
ZA885417B ZA885417A ZA885417A ZA885417B ZA 885417 B ZA885417 B ZA 885417B ZA 885417 A ZA885417 A ZA 885417A ZA 885417 A ZA885417 A ZA 885417A ZA 885417 B ZA885417 B ZA 885417B
Authority
ZA
South Africa
Prior art keywords
pharmaceutical composition
case
intranasal administration
bile salt
releasing hormone
Prior art date
Application number
ZA885417A
Other languages
English (en)
Inventor
Franklin M Boghen
M Boghen Franklin
Franco Camanni
Camanni Franco
Piero Del Soldato
Del Soldato Piero
Ezio Ghigo
Ghigo Ezio
Eugenio E Muller
E Muller Eugenio
Original Assignee
Pierrel Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pierrel Spa filed Critical Pierrel Spa
Publication of ZA885417B publication Critical patent/ZA885417B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH], i.e. somatotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/25—Growth hormone-releasing factor [GH-RF], i.e. somatoliberin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Otolaryngology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
ZA885417A 1987-07-30 1988-07-25 Pharmaceutical composition for intranasal administration,comprising gh-releasing hormone,a cholinergic agonist and in case a bile salt ZA885417B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT21513/87A IT1222395B (it) 1987-07-30 1987-07-30 Composizione farmaceutica per somministrazione intranasale comprendente l'ormone ghrh,un agonista colinergico e/o un sale biliare

Publications (1)

Publication Number Publication Date
ZA885417B true ZA885417B (en) 1989-06-28

Family

ID=11182925

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA885417A ZA885417B (en) 1987-07-30 1988-07-25 Pharmaceutical composition for intranasal administration,comprising gh-releasing hormone,a cholinergic agonist and in case a bile salt

Country Status (12)

Country Link
US (1) US5010056A (ko)
EP (1) EP0301392B1 (ko)
JP (1) JPS6450823A (ko)
KR (1) KR890001584A (ko)
AT (1) ATE76753T1 (ko)
AU (1) AU618547B2 (ko)
DK (1) DK393188A (ko)
IT (1) IT1222395B (ko)
NO (1) NO883200L (ko)
NZ (1) NZ225546A (ko)
PH (1) PH26712A (ko)
ZA (1) ZA885417B (ko)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0383931A (ja) * 1989-08-29 1991-04-09 Sumitomo Pharmaceut Co Ltd 低刺激性ｇｒｆ経鼻投与製剤
EP0432431B1 (en) * 1989-11-16 1993-06-16 PHIDEA S.p.A. Liquid pharmaceutical composition for nasal administration containing a polypeptide as active ingredient
US5502067A (en) * 1994-02-04 1996-03-26 Morgan; Julia A. Treating apneahypopnea/snoring in humans
US5500205A (en) * 1994-02-23 1996-03-19 Enviro Pac International, L.I.C. Lachrymator aerosol formulations
US5861431A (en) * 1995-06-07 1999-01-19 Iotek, Inc. Incontinence treatment
AUPN801296A0 (en) 1996-02-12 1996-03-07 Csl Limited Stabilised growth hormone formulation and method of preparation thereof
US8048875B1 (en) 1997-02-24 2011-11-01 S.L.A. Pharma Ag Topical pharmaceutical composition comprising a cholinergic agent or a calcium channel blocker
EP1250927A3 (en) * 1997-02-24 2003-03-26 S.L.A. Pharma AG Pharmaceutical composition for topical application comprising nifedipine
AU772798B2 (en) * 1999-04-21 2004-05-06 1355540 Ontario Inc. Formulations for detecting asthma
JP2005505491A (ja) * 1999-06-02 2005-02-24 ヘキサル・アクチェンゲゼルシャフト 水溶性活性物質の鼻腔内投与用医薬組成物
WO2001041732A1 (en) * 1999-12-06 2001-06-14 Gore Stanley L Compositions and methods for intranasal delivery of active agents to the brain
JP3498041B2 (ja) 2000-05-29 2004-02-16 科研製薬株式会社 プラルモレリン含有点鼻用製剤
US8299079B2 (en) * 2009-05-22 2012-10-30 Kaufman Herbert E Preparations and methods for ameliorating or reducing presbyopia
US20100298335A1 (en) * 2009-05-22 2010-11-25 Kaufman Herbert E Preparations and Methods for Ameliorating or Reducing Presbyopia
BR112016002268B1 (pt) * 2013-08-01 2022-11-01 The Penn State Research Foundation Uso de inibidores do receptor x farnesoide

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3371281D1 (en) * 1982-12-10 1987-06-11 Syntex Inc Lhrh preparations for intranasal administration
JPS59163313A (ja) * 1983-03-09 1984-09-14 Teijin Ltd 経鼻投与用ペプチドホルモン類組成物
IT1169873B (it) * 1983-10-21 1987-06-03 Prodotti Formenti Srl Composizione farmaceutica ad attivita' sistemica anticolinesterasica, agonista-colinergica ed antimuscarinica
US4818531A (en) * 1985-02-06 1989-04-04 Eli Lilly And Company Growth hormone and thyroid hormone
JPS62126135A (ja) * 1985-11-25 1987-06-08 Sumitomo Pharmaceut Co Ltd 経鼻投与用ｇｒｆ製剤
US4663318A (en) * 1986-01-15 1987-05-05 Bonnie Davis Method of treating Alzheimer's disease
US4880778A (en) * 1986-05-12 1989-11-14 Eastman Kodak Company Combinations having synergistic growth hormone releasing activity and methods for use thereof

Also Published As

Publication number Publication date
IT1222395B (it) 1990-09-05
NO883200L (no) 1989-01-31
AU2005188A (en) 1989-02-02
PH26712A (en) 1992-09-15
DK393188A (da) 1989-01-31
KR890001584A (ko) 1989-03-27
US5010056A (en) 1991-04-23
AU618547B2 (en) 1992-01-02
NO883200D0 (no) 1988-07-19
ATE76753T1 (de) 1992-06-15
EP0301392A1 (en) 1989-02-01
IT8721513A0 (it) 1987-07-30
JPS6450823A (en) 1989-02-27
NZ225546A (en) 1990-12-21
EP0301392B1 (en) 1992-06-03
DK393188D0 (da) 1988-07-14

Similar Documents

Publication Publication Date Title
EP0301392B1 (en) Pharmaceutical composition for intranasal administration comprising gh - releasing hormone, a cholinergic agonist and in case a bile salt
EP0242643A3 (en) Nasal administration of drugs
AU8199187A (en) A liquid dosage form for oral administration of a pharmaceutically active substance
EP0274431A3 (en) Drug delivery compositions and methods
UA42747C2 (uk) Похідні пептиду,фармацевтична композиція та спосіб стимулювання секреції гормону росту
MY103352A (en) Piperazinyl-heterocyclic compounds
AU2804489A (en) New device and new method for drug administration
OA08214A (en) Apparatus and methodology for pulsed administration of growth promoting agents.
IT1218548B (it) Perno autofilettante per l'impianto di protesi dentali
MX9704030A (es) 1,1-dioxidos de 2-heterocicliloxi y tiometil-1,2,5-tiadiazolidin-3-ona y composiciones y metodo de uso de los mismos.
GB8806737D0 (en) Therapeutic composition & method
MX9704037A (es) 1,1-dioxidos de 1,2,5-tiadiazolidin-3-ona 2-substituida y composiciones y metodo de uso de los mismos.
EP0204447A3 (en) Pharmaceutical preparations which may be used for stimulating tear secretion
GR3006815T3 (ko)
AU2807689A (en) Method for the treatment of body tissues and the administration of drugs thereto
MY103210A (en) Arylpiperazinyl-alkylene-phenyl-heterocyclic compounds.
MX9704034A (es) Derivados y composiciones de 1,1-dioxido de 2-arilcarboniloximetil-1,2,5-tiadiazolidin-3-ona substituido y metodo de uso.
EP0266993A3 (en) Method and therapeutic compositions for the treatment of bleeding disorders
NZ231320A (en) Aqueous oral preparations of diclofenac
ZA894945B (en) Strontium salt,process for the preparation thereof and pharmaceutical compositions containing it
PH24723A (en) Device and composition for treatment of the gums
AU2908389A (en) Device for administering medicaments by atomization in intubated or tracheotomized patients
GR3001277T3 (en) Chlorpheniramine therapy
EP0349589A4 (en) PHARMACOLOGICALLY ACTIVE CHOLINERGE PREPARATIONS AND METHOD FOR THE PRODUCTION AND THEIR USE FOR TREATING DISEASES.
NZ216246A (en) 2-azabicyclo(3.3.0 -7-octene-3-carboxylic acid derivatives and pharmaceutical compositions